JAMIE WADE: Open Payments
NPI 1225730997 · WILKES-BARRE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$537 in 18 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $537
Food & beverage: $537
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 9 | $223 |
| Alkermes, Inc. | 3 | $165 |
| Janssen Pharmaceuticals, Inc | 2 | $49 |
| ABBVIE INC. | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 1 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
Products named: UZEDY, ARISTADA, INVEGA SUSTENNA, VRAYLAR, FANAPT, ABILIFY ASIMTUFII, AUSTEDO XR.
Industry payments across PA — which companies pay providers there.
